Wealth creation and disease burden: Evidence from Nigeria based on a Bayesian-VAR approach

Does wealth creation reduce disease burden for developing countries? In this paper a Bayesian-VAR (B-VAR) model is built to investigate the causal relationships between disease burden, wealth creation, life expectancy at birth and population growth over the period from 2006 to 2018 in Nigeria, a developing country with significant disease burden. Specifically, the use of the impulse response functions and the forecast variance decomposition functions reveal that wealth creation has the greatest impact on disease burden in Nigeria. Our results are consistent with different measurements of wealth creation, including trade in services, personal remittance received, and ease of doing business. We have also found a pronounced response of disease burden to life expectancy at birth and to population growth. Our results suggest that, in Nigeria, policies targeted at wealth creation, with a proper wealth redistribution, are strongly recommended to reduce disease burden and increase life expectancy at birth.

• Publication year

  2025

• Venue

  PLoS ONE

• Publication date

  2025-11-10

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1371/journal.pone.0334709PMID 41212879PMCID 12599923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caesarean section and associated factors in Nigeria: assessing inequalities between rural and urban areas—insights from the Nigeria Demographic and Health Survey 2018

  2024cited by this paper
• Antenatal care utilisation and receipt of its components in Nigeria: Assessing disparities between rural and urban areas—A nationwide population-based study

  2024cited by this paper
• Healthy life expectancy for 202 countries up to 2030: Projections with a Bayesian model ensemble

  2023cited by this paper
• Tracking Universal Health Coverage

  2021cited by this paper
• An assessment of the contribution of healthcare expenditure to life expectancy at birth in Nigeria

  2021cited by this paper
• The Doing Business ranking and the GDP. A qualitative study

  2020cited by this paper
• Population growth and human resource utilization nexus in Nigeria

  2020cited by this paper
• The effects of ageing population on health expenditure and economic growth in China: A Bayesian-VAR approach.

  2020cited by this paper
• The macroeconomic impact of shocks to bank capital buffers in the Euro Area

  2019cited by this paper
• Monetary policy, crisis and capital centralization in corporate ownership and control networks: A B-Var analysis

  2019cited by this paper
• The Effect of Ease of Doing Business on Firm Creation

  2018cited by this paper
• The contribution of urbanization to non‐communicable diseases: Evidence from 173 countries from 1980 to 2008

  2017cited by this paper
• The effects of population ageing on health care expenditure: A Bayesian VAR analysis using data from Italy.

  2017cited by this paper
• World Trade in Services: Evidence from a New Dataset

  2017cited by this paper
• Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations

  2016cited by this paper
• Transforming our world : The 2030 Agenda for Sustainable Development

  2016cited by this paper
• The Effect of Population Aging on Economic Growth, the Labor Force, and Productivity

  2016cited by this paper
• Plos One

  2015cited by this paper
• Life expectancy and education: evidence from the cardiovascular revolution

  2015cited by this paper
• The Epidemiologic Transition

  2015cited by this paper
• Measuring the global burden of disease.

  2013influential reference
• Where wealth matters more for health: the wealth-health gradient in 16 countries.

  2013cited by this paper
• Bayesian Multivariate Time Series Methods for Empirical Macroeconomics

  2010cited by this paper
• VARs, common factors and the empirical validation of equilibrium business cycle models

  2006cited by this paper
• The epidemiologic transition: a theory of the epidemiology of population change. 1971.

  2005cited by this paper
• Health and endogenous growth.

  2001cited by this paper
• Monetary Policy Shocks: What Have We Learned and to What End?" in The Handbook of Macroeconomics

  1998cited by this paper
• Global burden of disease.

  1997cited by this paper
• Diet, Nutrition, and the Prevention of Chronic Diseases

  1994cited by this paper
• Diet, nutrition, and the prevention of chronic diseases. Report of a WHO Study Group.

  1990cited by this paper
• Forecasting with Bayesian vector autoregressions — Five years of experience: Robert B. Litterman, Journal of Business and Economic Statistics 4 (1986) 25–38

  1986influential reference
• Forecasting and Conditional Projection Using Realistic Prior Distributions

  1983cited by this paper
• MACROECONOMICS AND REALITY

  1977cited by this paper
• The Demand for Health: A Theoretical and Empirical Investigation

  1974cited by this paper
• A utility maximization model for evaluation of health care programs.

  1972cited by this paper
• The epidemiologic transition. A theory of the epidemiology of population change.

  1971cited by this paper
• Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease

  1968cited by this paper
• UNICEF

  1949cited by this paper
• Department of Economics Working Paper Series Economic Growth, Longevity, and the Epidemiological Transi- Tion

  year unknowncited by this paper

• No citing papers are available for this paper.